NCIt definition : A humanized monoclonal antibody directed against the epidermal growth factor receptor
(EGFR) with potential antineoplastic activity. Nimotuzumab binds to and inhibits EGFR,
resulting in growth inhibition of tumor cells that overexpress EGFR. This agent may
act synergistically with radiation therapy.;
Alternative definition : NCI-GLOSS: A monoclonal antibody being studied in the treatment of some types of cancer.
Monoclonal antibodies are made in the laboratory and can locate and bind to substances
in the body, including cancer cells. Nimotuzumab binds the epidermal growth factor
receptor (EGFR) and blocks cancer cells that depend on epidermal growth factor for
growth.;
UNII : 6NS400BXKH;
CAS number : 828933-51-3; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 828933-51-3
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;
Drug name : Theraloc;
Molecule name : H-R3;
Codes from synonyms : CDR0000538634; CDR0000572210;